A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets

Clinical trial NCT07170800 · RECRUITING

Trial details

NCT number: NCT07170800
Sponsor: WestVac Biopharma Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Tuberculosis Multidrug Resistant Pulmonary Tuberculosis Rifampicin-resistant Tuberculosis

Start date: 2025-09-19
Primary completion: 2026-02-28
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.